[Unnoticed loss of renal function during treatment with angiotensin I converting enzyme inhibitor. A new risk in patients with unrecognized unilateral stenosis of the renal artery].
When patients with functional unilateral renal artery stenosis are treated with an angiotensin I converting enzyme inhibitor (ACE-inhibitor) a risk is present for loss of the function of the affected kidney without clinical symptoms. Renal function should therefore be controlled in these patients before and after initiation of the treatment. Even a slight increase in serum creatinine must be followed by reassessment of the treatment and investigation for renocascular hypertension must be considered.
Tingleff
J
J
Strandgaard
S
S
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D008875:Middle Aged; D012078:Renal Artery Obstruction / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors
Ubemaerket tab af nyrefunktion under behandling med angiotensin I konverterende enzymhaemmer. En ny risiko hos patienter med ikke-erkendt ensidig nyrearteriestenose.